Alternatives to Traditional Unit Operations Are Now Available to Alleviate Very Real Logjams Due to the complexity of therapeutic protein purification, downstream bioprocess bottlenecks can arise from ...

Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

Master of Biotechnology program (MBP) student Anita Huang looks back on her six-month internship at UCB in the United Kingdom and what she learned from the experience. In 2019, two students in ...

With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...

A research team led by the University of Delaware’s Kelvin Lee is working to change that. Lee, the Gore Professor of Chemical ...

Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the manufacturing of biological drugs. A recent publication ...

Standards organization says R2v3 certification entails accurately portraying operations of facilities receiving components and materials. SERI says qualifications for a non-R2v3 downstream vendor are ...

PERTH (miningweekly.com) – Diversified miner Independence Group has lodged a patent application for a new process to produce high quality nickel sulphate from nickel sulphide concentrate. The company ...

Petróleo Brasileiro SA (Petrobras) is resuming receipt of binding offers for its previously announced program to divest its Brazilian refining and related logistics assets following a previous delay ...